All News

Top News of the Week from Directions in Specialty Pharmacy

Top news from across the health care landscape.

The New Mexico House and Senate recently passed a bill that would require insurance companies to reimburse pharmacists who provide clinical services and prescribe medications.

Gilead has agreed to pay $95.50 per share in cash for Forty Seven Inc, adding the 5-year old biotechnology company to bolster its portfolio of oncology drugs.

Do you know which state is the home of Dr. Pepper?

The National Association of Specialty Pharmacy opened registration for its eighth Annual Meeting & Expo, to be held Sept. 14 - 17 at the Washington Marriott Wardman Park in Washington, D.C.

Pharmacies can generate an average of $8800 per month from services such as consultations, educational classes, and immunizations.

Many pharmacists are speaking out about understaffing and stressful work environments, all of which leads to potentially dangerous errors.

The act aims to mitigate common triggers of drug shortages by improving transparency throughout the drug supply chain process, and strengthening FDA interagency efforts to prevent shortages.

The United States now has more than 100 confirmed cases and 10 deaths, according to the CDC.

Among insured adults with diabetes in the United States, 40% struggle to pay for care according to a new report.

Online pharmacy Valisure has found high levels of N-Nitrosodimethylamine (NDMA), a probable human carcinogen, in batches of metformin from 11 out of 22 tested manufacturers.1

The FDA is now requiring a boxed warning for montelukast (Singulair) to strengthen the existing warning about the risk of neuropsychiatric events.

In addition, the new legislation calls for more intervention from local and state health officers, allowing them to recommend options ranging from testing to counseling. This includes the ability to mandate treatment for an individual determined to be placing others at risk.

Pharmacy managers invariably face employees suffering from various personal issues that require special attention and/or counseling, and at some point will be confronted with the issue of an impaired employee.

Study demonstrates an association between low maternal vitamin D level in early to mid-pregnancy and an elevated risk for diagnosed attention-deficit/hyperactivity disorder in the offspring.

In recognition of National Kidney month, the National Kidney Foundation has announced a partnership with CVS Kidney Care to raise awareness about kidney disease.

Using the 2012 to 2017 Medicare Part D Drug Event and Medicaid Spending and Utilization data sets, the researchers analyzed 20 extended-release drugs with 37 Medicare formulations and 36 Medicaid formulations. The analyses were conducted from January to December 2019.

Antioxidant supplements do not improve fertility among men, pregnancy, or live birth rates, a study found.

A study offers evidence that chimeric antigen receptor T-cell therapy may not only extend patients’ survival, but also improve their quality of life after treatment.

Top news from across the health care landscape.

Scientists at the Gladstone Institutes have cataloged host proteins that physically bind to HIV proteins, which identify human proteins that the virus can use to infect cells and spread.

By changing the definition of biological products and hopefully increasing access to cheaper insulin, the FDA hopes to do just that.

AL101 is a potent, selective, injectable small molecule gamma secretase inhibitor and was granted Orphan Drug designation in May 2019 for the treatment of ACC.

The bill is intended to "prevent a health insurance carrier from requiring a covered person to undergo step therapy or to receive prior authorization before receiving HIV infection prevention drugs."

Pharmacists should be aware of what drug repurposing is and how it occurs as due to the vast amount of opportunities that exist.

Top news from across the health care landscape.

The designation was granted to Emerald Health Pharmaceuticals’ EHP-101, an oral formulation of a novel aminoquinone synthetic derivative of cannabidiol endowed with dual peroxisome proliferator-activated receptor gamma and cannabinoid receptor type 2 agonist activity.

The Undectectable = Untransmittable (U=U) campaign started in early 2016 and has been sharing the message to dismantle the stigma surrounding HIV ever since. More than 970 community partners from 101 countries have come together to clear up the confusion about the science behind U=U.

Pharmacy Times® will publish a technician supplement in July 2020.